On Stockhead today, how ASX hydrogen players can become superpower producers, how pro investors assess full-year results, and Bottom Picker goes to Rio.

But first … the day ahead. 

TRADING HALTS

The following companies are in trading halts and are expected out in the next two trading days:

Monday

Creso Pharma (ASX:CPH) – Health Canada license
Galan Lithium (ASX:GLN) – capital raising
Dimerix (ASX:DXB) – capital raising
Alexium (ASX:AJX) – sales update clarification 

Tuesday

Nuheara (ASX:NUH) – clinical trial commencement
African Energy Resources (ASX:AFR) – capital raising
Alkane Resources (ASX:ALK) – exploration results
Firefinch (ASX:FFX) – joint venture update
Dropsuite (ASX:DSE) – capital raising

 

MARKETS

Gold: $US1,779.45 ($2,414.09) (+1.54%)

Silver: $US23.73 ($32.19) (+2.48%)

Oil (WTI): $US68.03 (-1.53%)

Oil (Brent): $US69.83 (-1.08%)

Coal: $US172.25 (+0.58%)

Iron 62pc Fe: $US167.95 (+0.01%)

AUD/USD: $US0.7368 (+0.01%)

Bitcoin: $US46,790.64 (-0.12%)

 

WHAT GOT YOU TALKING YESTERDAY?

PPK Group’s 10,000% share price rise over the last five years got your attention.

And someone made $600K flipping a penguin NFT.

To keep up to date with Stockhead coverage, follow our Twitter page or sign up to our members-only Facebook group here.

For all you crypto lovers Stockhead’s Cryptohead Facebook group is the place to share your views, insights, tips and ideas.

Also, be sure to check in at 10.20am each day for our daily ‘10 at 10’ column — a live summary of winners & losers at the opening bell.

 

FRIDAY’S WINNERS

Scroll or swipe to reveal table. Click headings to sort.

Stocks highlighted in yellow rose after making announcements during intraday trade.

Wordpress Table Plugin

None of the top 25 ASX stocks rose off the back of announcements. But one notable winner was Australian Rare Earths (ASX:AR3), which gained another 16% Friday and is now up 292% since its IPO at the start of July.

 

FRIDAY’S LOSERS

Wordpress Table Plugin

Pot stock Cann Group (ASX:CAN) terminated its agreement with Emyria (ASX:EMD), which could have seen the pair register a schedule 3 over-the-counter cannabidiol medicine product with the TGA.